COVID-19 and male reproduction: Current research and unknown factors.

Abstract

BackgroundThe testes are suspected target organs of SARS‐CoV‐2. However, the results of studies on the effect of COVID‐19 on male reproduction are controversial.ObjectiveTo summarize current research on the effects of COVID‐19 on male reproduction.MethodsA systematic review of English literature was performed using PubMed and Ovid Embase up to 18 August 2020. Research articles on the presence of SARS‐CoV‐2 in semen, the effects of the virus on semen parameters and any pathological changes in the testes were evaluated.ResultsFourteen studies were included in this review. Six of 176 survivors (3.4%) and 1 of 13 decedents (7.7%) in 2 of 12 studies were positive for viral RNA in semen and testicular tissue, respectively. After stratification of patient groups, we found that the virus was detected in the relatively early stage of infection, 6–16 days after disease onset, in semen from survivors. Two of 3 studies reported that some participants had substandard semen quality after COVID‐19, and 1 study found that COVID‐19 may impair semen quality in a severity‐related manner. Pathological analyses showed that injuries to the seminiferous tubule occurred in all decedents (N = 11). Another study found that orchitic and testis fibrin microthrombi occurred in patients with fatal disease (100%, N = 2). Scrotal discomfort of orchiepididymitis or spermatic cord inflammation has also been reported in COVID‐19 patients.ConclusionCurrent studies suggest that semen is rarely considered a carrier of SARS‐CoV‐2 genetic material during the infection period but not in the semen of recovered patients. Fatal COVID‐19 may cause testicular structure damage without the presence of virus.